ID   AVR2A_HUMAN             Reviewed;         513 AA.
AC   P27037; B2RAB8; B4DWQ2; D3DP85; Q53TH4; Q6NWV2; Q92474;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   10-MAY-2017, entry version 182.
DE   RecName: Full=Activin receptor type-2A;
DE            EC=2.7.11.30;
DE   AltName: Full=Activin receptor type IIA;
DE            Short=ACTR-IIA;
DE            Short=ACTRIIA;
DE   Flags: Precursor;
GN   Name=ACVR2A; Synonyms=ACVR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=1311955; DOI=10.1016/0167-4781(92)90472-C;
RA   Matzuk M.M., Bradley A.;
RT   "Cloning of the human activin receptor cDNA reveals high evolutionary
RT   conservation.";
RL   Biochim. Biophys. Acta 1130:105-108(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Testis;
RX   PubMed=1314589; DOI=10.1016/0006-291X(92)91194-U;
RA   Donaldson C.J., Mathews L.S., Vale W.W.;
RT   "Molecular cloning and binding properties of the human type II activin
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 184:310-316(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RA   Geiser A.G.;
RL   Submitted (DEC-1991) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Iimura T., Oida S.;
RL   Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 191-488 IN COMPLEX WITH
RP   DORSOMORPHIN.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of activin receptor type-IIa (ACVR2A) kinase domain
RT   in complex with dorsomorphin.";
RL   Submitted (FEB-2011) to the PDB data bank.
RN   [10]
RP   VARIANTS ARG-258 AND ASN-306.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [11]
RP   VARIANT THR-367.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: On ligand binding, forms a receptor complex consisting
CC       of two type II and two type I transmembrane serine/threonine
CC       kinases. Type II receptors phosphorylate and activate type I
CC       receptors which autophosphorylate, then bind and activate SMAD
CC       transcriptional regulators. Receptor for activin A, activin B and
CC       inhibin A. Mediates induction of adipogenesis by GDF6 (By
CC       similarity). {ECO:0000250|UniProtKB:P27038,
CC       ECO:0000269|PubMed:1314589}.
CC   -!- CATALYTIC ACTIVITY: ATP + [receptor-protein] = ADP + [receptor-
CC       protein] phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with AIP1. Part of a complex consisting of
CC       AIP1, ACVR2A, ACVR1B and SMAD3 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P27037-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P27037-2; Sequence=VSP_054689;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ACVR2ID567ch2q22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X63128; CAA44839.1; -; mRNA.
DR   EMBL; M93415; AAA35504.1; -; mRNA.
DR   EMBL; X62381; CAA44245.1; -; mRNA.
DR   EMBL; D31770; BAA06548.1; -; mRNA.
DR   EMBL; AK301629; BAG63114.1; -; mRNA.
DR   EMBL; AK314124; BAG36815.1; -; mRNA.
DR   EMBL; AC009480; AAX93050.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11561.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11562.1; -; Genomic_DNA.
DR   EMBL; BC067418; AAH67418.1; -; mRNA.
DR   EMBL; BC067417; AAH67417.1; -; mRNA.
DR   EMBL; BC069707; AAH69707.1; -; mRNA.
DR   CCDS; CCDS33301.1; -. [P27037-1]
DR   CCDS; CCDS63030.1; -. [P27037-2]
DR   PIR; JQ1486; JQ1486.
DR   RefSeq; NP_001265508.1; NM_001278579.1. [P27037-1]
DR   RefSeq; NP_001265509.1; NM_001278580.1. [P27037-2]
DR   RefSeq; NP_001607.1; NM_001616.4. [P27037-1]
DR   UniGene; Hs.470174; -.
DR   PDB; 3Q4T; X-ray; 1.96 A; A/B=191-488.
DR   PDB; 3SOC; X-ray; 1.95 A; A/B=191-488.
DR   PDB; 4ASX; X-ray; 2.05 A; A/B=191-488.
DR   PDBsum; 3Q4T; -.
DR   PDBsum; 3SOC; -.
DR   PDBsum; 4ASX; -.
DR   ProteinModelPortal; P27037; -.
DR   SMR; P27037; -.
DR   BioGrid; 106607; 32.
DR   DIP; DIP-520N; -.
DR   IntAct; P27037; 1.
DR   MINT; MINT-122188; -.
DR   STRING; 9606.ENSP00000241416; -.
DR   BindingDB; P27037; -.
DR   ChEMBL; CHEMBL5616; -.
DR   GuidetoPHARMACOLOGY; 1791; -.
DR   iPTMnet; P27037; -.
DR   PhosphoSitePlus; P27037; -.
DR   DMDM; 114722; -.
DR   EPD; P27037; -.
DR   MaxQB; P27037; -.
DR   PaxDb; P27037; -.
DR   PeptideAtlas; P27037; -.
DR   PRIDE; P27037; -.
DR   DNASU; 92; -.
DR   Ensembl; ENST00000241416; ENSP00000241416; ENSG00000121989. [P27037-1]
DR   Ensembl; ENST00000404590; ENSP00000384338; ENSG00000121989. [P27037-1]
DR   Ensembl; ENST00000535787; ENSP00000439988; ENSG00000121989. [P27037-2]
DR   GeneID; 92; -.
DR   KEGG; hsa:92; -.
DR   UCSC; uc002twg.5; human. [P27037-1]
DR   CTD; 92; -.
DR   DisGeNET; 92; -.
DR   GeneCards; ACVR2A; -.
DR   HGNC; HGNC:173; ACVR2A.
DR   HPA; HPA046997; -.
DR   MIM; 102581; gene.
DR   neXtProt; NX_P27037; -.
DR   OpenTargets; ENSG00000121989; -.
DR   PharmGKB; PA24494; -.
DR   eggNOG; KOG3653; Eukaryota.
DR   eggNOG; ENOG410XS2Z; LUCA.
DR   GeneTree; ENSGT00760000118876; -.
DR   HOGENOM; HOG000231495; -.
DR   HOVERGEN; HBG054502; -.
DR   InParanoid; P27037; -.
DR   KO; K04670; -.
DR   OMA; SCYGDKD; -.
DR   OrthoDB; EOG091G03YO; -.
DR   PhylomeDB; P27037; -.
DR   TreeFam; TF352876; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-1181150; Signaling by NODAL.
DR   Reactome; R-HSA-1433617; Regulation of signaling by NODAL.
DR   Reactome; R-HSA-1502540; Signaling by Activin.
DR   Reactome; R-HSA-201451; Signaling by BMP.
DR   SignaLink; P27037; -.
DR   SIGNOR; P27037; -.
DR   EvolutionaryTrace; P27037; -.
DR   GeneWiki; ACVR2A; -.
DR   GenomeRNAi; 92; -.
DR   PRO; PR:P27037; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000121989; -.
DR   CleanEx; HS_ACVR2A; -.
DR   Genevisible; P27037; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC.
DR   GO; GO:0034673; C:inhibin-betaglycan-ActRII complex; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IPI:BHF-UCL.
DR   GO; GO:0048185; F:activin binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0098821; F:BMP receptor activity; ISS:UniProtKB.
DR   GO; GO:0015026; F:coreceptor activity; IDA:BHF-UCL.
DR   GO; GO:0019838; F:growth factor binding; IEA:Ensembl.
DR   GO; GO:0034711; F:inhibin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; IEA:Ensembl.
DR   GO; GO:0043621; F:protein self-association; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IEA:InterPro.
DR   GO; GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0032924; P:activin receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IMP:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl.
DR   GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
DR   GO; GO:0043084; P:penile erection; IEA:Ensembl.
DR   GO; GO:0032927; P:positive regulation of activin receptor signaling pathway; IDA:HGNC.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; IDA:HGNC.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0030510; P:regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; IEA:Ensembl.
DR   GO; GO:0060011; P:Sertoli cell proliferation; IEA:Ensembl.
DR   GO; GO:0042713; P:sperm ejaculation; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; TAS:ProtInc.
DR   InterPro; IPR000472; Activin_recp.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR000333; TGFB_receptor.
DR   PANTHER; PTHR23255; PTHR23255; 1.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00653; ACTIVIN2R.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Disulfide bond; Glycoprotein; Kinase; Magnesium; Manganese; Membrane;
KW   Metal-binding; Nucleotide-binding; Polymorphism; Receptor;
KW   Reference proteome; Serine/threonine-protein kinase; Signal;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    513       Activin receptor type-2A.
FT                                /FTId=PRO_0000024398.
FT   TOPO_DOM     20    135       Extracellular. {ECO:0000255}.
FT   TRANSMEM    136    161       Helical. {ECO:0000255}.
FT   TOPO_DOM    162    513       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      192    485       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     198    206       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    322    322       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     219    219       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   CARBOHYD     43     43       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     30     60       {ECO:0000250|UniProtKB:P27038}.
FT   DISULFID     50     78       {ECO:0000250|UniProtKB:P27038}.
FT   DISULFID     85    104       {ECO:0000250|UniProtKB:P27038}.
FT   DISULFID     91    103       {ECO:0000250|UniProtKB:P27038}.
FT   DISULFID    105    110       {ECO:0000250|UniProtKB:P27038}.
FT   VAR_SEQ       1    108       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054689.
FT   VARIANT     258    258       S -> R (in dbSNP:rs34917571).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_032809.
FT   VARIANT     306    306       D -> N (in a gastric adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs764255410).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_032810.
FT   VARIANT     367    367       A -> T (found in a clear cell renal
FT                                carcinoma case; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064692.
FT   CONFLICT     13     13       L -> V (in Ref. 4; BAA06548).
FT                                {ECO:0000305}.
FT   CONFLICT    204    206       GCV -> PSL (in Ref. 4; BAA06548).
FT                                {ECO:0000305}.
FT   CONFLICT    348    348       E -> V (in Ref. 4; BAA06548).
FT                                {ECO:0000305}.
FT   CONFLICT    507    507       P -> L (in Ref. 8; AAH67417).
FT                                {ECO:0000305}.
FT   STRAND      191    199       {ECO:0000244|PDB:3SOC}.
FT   STRAND      205    211       {ECO:0000244|PDB:3SOC}.
FT   STRAND      214    221       {ECO:0000244|PDB:3SOC}.
FT   HELIX       223    225       {ECO:0000244|PDB:3SOC}.
FT   HELIX       226    236       {ECO:0000244|PDB:3SOC}.
FT   STRAND      249    256       {ECO:0000244|PDB:3SOC}.
FT   STRAND      258    268       {ECO:0000244|PDB:3SOC}.
FT   HELIX       275    281       {ECO:0000244|PDB:3SOC}.
FT   HELIX       286    303       {ECO:0000244|PDB:3SOC}.
FT   STRAND      307    310       {ECO:0000244|PDB:3SOC}.
FT   STRAND      313    315       {ECO:0000244|PDB:3SOC}.
FT   STRAND      317    319       {ECO:0000244|PDB:3SOC}.
FT   STRAND      327    330       {ECO:0000244|PDB:3SOC}.
FT   STRAND      336    338       {ECO:0000244|PDB:3SOC}.
FT   STRAND      345    347       {ECO:0000244|PDB:3SOC}.
FT   HELIX       363    365       {ECO:0000244|PDB:3SOC}.
FT   HELIX       368    371       {ECO:0000244|PDB:3SOC}.
FT   HELIX       379    398       {ECO:0000244|PDB:3SOC}.
FT   STRAND      404    406       {ECO:0000244|PDB:3SOC}.
FT   HELIX       416    419       {ECO:0000244|PDB:3SOC}.
FT   HELIX       425    432       {ECO:0000244|PDB:3SOC}.
FT   HELIX       443    446       {ECO:0000244|PDB:3SOC}.
FT   HELIX       449    461       {ECO:0000244|PDB:3SOC}.
FT   HELIX       466    468       {ECO:0000244|PDB:3SOC}.
FT   HELIX       472    485       {ECO:0000244|PDB:3SOC}.
SQ   SEQUENCE   513 AA;  57848 MW;  A89822E880979618 CRC64;
     MGAAAKLAFA VFLISCSSGA ILGRSETQEC LFFNANWEKD RTNQTGVEPC YGDKDKRRHC
     FATWKNISGS IEIVKQGCWL DDINCYDRTD CVEKKDSPEV YFCCCEGNMC NEKFSYFPEM
     EVTQPTSNPV TPKPPYYNIL LYSLVPLMLI AGIVICAFWV YRHHKMAYPP VLVPTQDPGP
     PPPSPLLGLK PLQLLEVKAR GRFGCVWKAQ LLNEYVAVKI FPIQDKQSWQ NEYEVYSLPG
     MKHENILQFI GAEKRGTSVD VDLWLITAFH EKGSLSDFLK ANVVSWNELC HIAETMARGL
     AYLHEDIPGL KDGHKPAISH RDIKSKNVLL KNNLTACIAD FGLALKFEAG KSAGDTHGQV
     GTRRYMAPEV LEGAINFQRD AFLRIDMYAM GLVLWELASR CTAADGPVDE YMLPFEEEIG
     QHPSLEDMQE VVVHKKKRPV LRDYWQKHAG MAMLCETIEE CWDHDAEARL SAGCVGERIT
     QMQRLTNIIT TEDIVTVVTM VTNVDFPPKE SSL
//
